Ergoteles LLC - CITIUS PHARMACEUTICALS INC ownership

CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 55 filers reported holding CITIUS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.0%.

Quarter-by-quarter ownership
Ergoteles LLC ownership history of CITIUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$460,000
+10.6%
380,063
-15.9%
0.02%
+33.3%
Q2 2022$416,000451,8900.01%
Other shareholders
CITIUS PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Inspire Advisors, LLC 198,632$232,3990.05%
GSA CAPITAL PARTNERS LLP 452,561$5290.05%
Wealth Advisory Solutions, LLC 155,850$182,3450.05%
CHELSEA COUNSEL CO 81,300$95,1210.05%
Horst & Graben Wealth Management LLC 75,722$89,0000.02%
Miller Investment Management, LP 50,000$58,5000.01%
Pasadena Private Wealth, LLC 10,965$12,8290.00%
Jump Financial, LLC 66,143$77,3870.00%
Lighthouse Investment Partners, LLC 36,126$42,2670.00%
BOOTHBAY FUND MANAGEMENT, LLC 75,188$87,9700.00%
View complete list of CITIUS PHARMACEUTICALS INC shareholders